Results 151 to 160 of about 2,698 (209)

Synthesis of Pyridazine Derivatives. III

YAKUGAKU ZASSHI, 1955
openaire   +2 more sources

Development of Pyrimido Pyridazine Analogs through Increased Whole Cell Target Engagement of the Dihydropteroate Synthase Pterin Binding Site in Gram-Negative Bacteria. [PDF]

ACS Infect Dis
Snoke HE, Reeve SM, Dharuman S, Wallace MJ, Loudon VC, Zhao Y, Bowling JJ, Murphy PA, Waddell B, Lee RB, Bulitta JB, Lee RE.   +11 more
europepmc   +1 more source

Deuteration of Six-Membered N-Heteroarenes: Chemistry and Applications. [PDF]

Chemistry
Raju L, Tiz DB, Iles A, Košmrlj J, Jansen-van Vuuren RD.   +4 more
europepmc   +1 more source

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]

ACS Chem Neurosci
Gregro AR, Park C, Long MF, Baker LA, Bollinger KA, Ringuette AE, Peng L, Luscombe VB, Billard NB, Rodriguez AL, Niswender CM, Peng W, Dickerson JW, Rook JM, O'Neill J, Chang S, Boonen HCM, Jensen T, Thomsen MS, Bridges TM, Boutaud O, Conn PJ, Engers DW, Lindsley CW, Temple KJ.   +24 more
europepmc   +1 more source

Synthesis of Pyridazine Derivatives. IV

YAKUGAKU ZASSHI, 1962
openaire   +3 more sources

Pyrazofurin Biosynthesis Involves Nonenzymatic Ring Contraction of a Pyridazine Intermediate Triggered by a Rieske Enzyme-Catalyzed Oxygenation. [PDF]

J Am Chem Soc
Zheng Z, Lee YH, Ren D, Liu HW.
europepmc   +1 more source

Investigation of Anticancer Properties of Newly Synthesized Pyridazine-Based Inhibitors in Mouse and Human Breast Cancer Cell Line. [PDF]

Biology (Basel)
Coskun KA, Abay EC, Gumus M, Çelik AB, Gulum L, Koca I, Tutar Y.   +6 more
europepmc   +1 more source

Triazenyl Furans as Diels-Alder Dienes. [PDF]

J Am Chem Soc
Budwitz JE, Hollers SA, Wester AR, Newton CG.   +3 more
europepmc   +1 more source

Synthesis, crystal structure and DFT study of carbon-yl[3-(dibenzo[<i>b</i>,<i>d</i>]thio-phen-4-yl)-6-(pyridin-2-yl-κ<i>N</i>)pyridazine-κ<i>N</i> ¹]bis-(tri-methyl-phosphane)iron(0). [PDF]

Acta Crystallogr E Crystallogr Commun
Futaki R, Chikaraishi Kasuga N, Hirotsu M.   +2 more
europepmc   +1 more source

Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview. [PDF]

Int J Mol Sci
Asproni B, Pinna GA, Corona P, Coinu S, Piras S, Carta A, Murineddu G.   +6 more
europepmc   +1 more source